Novanta stock rises after Q3 revenue jumps 23%
Published on 11/10/2026 at 02:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults and outlook shape investor focus
- Novanta reported third-quarter revenue growth while GAAP net income declined year over year.
- Management raised its full-year 2026 revenue and adjusted earnings outlook.
- A conference call was scheduled for Tuesday, November 10, to discuss the results and business update.
Novanta reported third-quarter 2026 results on Monday, November 9, with revenue growth and higher adjusted profitability but lower GAAP earnings. The company also lifted its full-year outlook, according to the Business Wire release via Yahoo Finance.
Novanta stock traded at 129.50 euros on Lang & Schwarz at 23:00 CET on Monday, November 9, 2026.
Revenue growth meets acquisition costs
Revenue reached 305.0 million US dollars for the quarter ended October 2, up 23.1 percent from 247.8 million US dollars a year earlier. The acquisition contribution added 13.3 percentage points to reported growth, while organic revenue growth was 9.9 percent.
GAAP operating income fell to 13.9 million US dollars from 21.8 million US dollars, and GAAP net income declined to 2.0 million US dollars from 10.7 million US dollars. Diluted GAAP earnings per share were 0.05 US dollars, compared with 0.30 US dollars in the prior-year quarter. Acquisition and related costs, restructuring costs and amortization were among the adjustments reflected in the reported results.
Adjusted EBITDA increased 38.3 percent to 80.3 million US dollars, lifting the adjusted EBITDA margin to 26.3 percent from 23.4 percent. Adjusted diluted earnings per share rose to 1.05 US dollars from 0.87 US dollars, while operating cash flow increased to 39.3 million US dollars from 8.5 million US dollars.
Guidance points to continued expansion
Novanta expects fourth-quarter revenue of 306 million to 312 million US dollars, adjusted EBITDA of 76 million to 79 million US dollars and adjusted diluted earnings per share of 0.91 to 0.96 US dollars. For the full year, management expects revenue of 1.135 billion to 1.140 billion US dollars, adjusted EBITDA of 274 million to 277 million US dollars and adjusted diluted earnings per share of 3.66 to 3.71 US dollars.
The company scheduled a conference call for Tuesday, November 10, at 8:00 a.m. Eastern Time to discuss the results and provide a business update. Management also said it expects reported revenue growth of more than 15 percent in 2027.
Novanta's technology business
Novanta supplies core technology solutions to medical, life science and advanced industrial original equipment manufacturers. Its capabilities include precision medicine, precision manufacturing, robotics and automation, and advanced surgery.
The company serves principal markets in North America, Europe and Asia Pacific. Novanta is incorporated under the laws of New Brunswick, Canada, and its common shares trade on Nasdaq under the ticker NOVT.
Novanta at a glance
- Company: Novanta Inc.
- ISIN: CA67000B1040
- Ticker: NOVT
- Home exchange: Nasdaq
- Price: 129.50 euros on Lang & Schwarz, November 9, 2026, 23:00 CET
The broader U.S. equity market remains the relevant trading backdrop for Novanta stock; see current Nasdaq market coverage.
More news and analyses on Novanta stock.
